Menu

More than Water

A comprehensive analysis of human urine identifies more than 3,000 metabolites. 

Sep 6, 2013
Erin Weeks

Hippuric acid, one of the most abundant organic metabolites in human urineFLICKR, SARAH OROS

Everything you ever wanted to know about the chemical makeup of human urine is now freely accessible in an online database, thanks to a team of researchers who are cataloguing their way through the complex metabolic compositions of bodily fluids. Studying the metabolome—or the sum of all metabolites in a biological sample—can reveal a wealth of information about how environmental factors affect human health. So far, the team has inventoried the metabolites found in blood serum, saliva, cerebrospinal fluid, and now, as reported in PLOS ONE this week (September 4), urine.

Urine does far more than eliminate water-soluble waste from our bodies. “While largely viewed as a waste product, urine has considerable value as a diagnostic biofluid,” the study’s authors write. Humans have leveraged that value for millennia, using urine to diagnose diseases from ancient Egypt to the Byzantine Empire. Today, urinalysis remains a noninvasive, cost-effective way to test for genetic disorders, renal conditions, and even some types of cancer.

To systematically characterize the metabolites found in human urine, the researchers searched existing literature and conducted their own extensive experiments using nuclear magnetic resonance spectroscopy, gas and liquid chromatography, and mass spectrometry. Previously, only a few hundred metabolites had been documented—a mere fraction of the 3,000 counted in this newest study.

To foster future research, the team established a comprehensive database of known urine metabolites. “We had no idea there could be so many different compounds going into our toilets,” lead author David Wishart from the University of Alberta told Popular Science

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.